Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla, N. Ramchandani, J. Trast, M. Cantwell, R. A. Heptulla

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm'. Together they form a unique fingerprint.